Feb 7 (Reuters) - Creso Pharma Ltd (CPH) : HALUCENEX LIFE SCIENCES EXPLORING OPPORTUNITIES TO REGISTER ITS SYNTHETIC PSILOCYBIN FORMULATION FOR AUSTRALIAN MARKET